Pharmacological assessment of spantide II analogues

European Journal of Pharmacology
Z Y WangR Håkanson

Abstract

We have studied the structure-activity relationship of a series of tachykinin receptor antagonists based on spantide II. Fifteen novel peptides were tested for their ability to antagonize the electrically evoked tachykinin receptor-mediated response in the isolated rabbit iris sphincter muscle. Substitution or deletion of one to three amino acids in the spantide II sequence caused significant changes in biological activity. Eight of the novel analogues were found to be as potent as or more potent than spantide II and some were found to have better water solubility. We tested the selectivity for different tachykinin receptors of spantide II and two of the eight most potent analogues. They all interacted with tachykinin NK1 (rabbit jugular vein) and tachykinin NK2 (rabbit pulmonary artery) receptors with pA2 values of about 6.5-7.5 at the NK1 receptor and of 5.9-7.2 at the NK2 receptor, while being inactive at the tachykinin NK3 receptor (rat portal vein). Spantide II and the novel analogues were without effect on electrically evoked cholinergic responses of the isolated rabbit iris sphincter and on electrically evoked sympathetic responses of the guinea-pig vas deferens; moreover, they were without local anaesthetic-like effects...Continue Reading

References

Apr 29, 1992·European Journal of Pharmacology·R PatacchiniC A Maggi
Sep 4, 1992·European Journal of Pharmacology·A W SchmidtJ Heym
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·K FolkersS Leander
Jan 25, 1991·Science·R M SniderR W Spencer
Jul 15, 1991·Biochemical and Biophysical Research Communications·R HåkansonK Folkers
Jun 18, 1991·European Journal of Pharmacology·C A MaggiK Folkers
Nov 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·C GarretP M Laduron
Apr 25, 1990·European Journal of Pharmacology·F NantelD Regoli
Nov 19, 1985·European Journal of Pharmacology·C PostC G Persson
Oct 29, 1985·European Journal of Pharmacology·P DevillierD Regoli
Mar 1, 1989·Regulatory Peptides·A LjungqvistK Folkers
Jan 1, 1988·Annual Review of Neuroscience·J E Maggio
Feb 24, 1987·European Journal of Pharmacology·D MastrangeloD Regoli
Nov 19, 1985·European Journal of Pharmacology·C WahlestedtR Håkanson
Aug 1, 1973·Toxicon : Official Journal of the International Society on Toxinology·P N StrongJ F Keana
Aug 1, 1974·Analytical Biochemistry·R Håkanson, A L Rönnberg
Dec 3, 1981·European Journal of Pharmacology·M Kurose, K Saeki
Feb 1, 1983·Acta Physiologica Scandinavica·R HåkansonJ Hörig
Oct 1, 1984·British Journal of Pharmacology·K FolkersS Leander
Dec 1, 1993·British Journal of Pharmacology·N M RupniakR G Hill
Feb 1, 1993·Journal of Autonomic Pharmacology·C A MaggiA Giachetti

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.